Telling your doctor exactly how much something hurts has always been a challenge but Monash University researchers have developed a clever solution that could take the guesswork out of pain diagnosis. On Sunday, scientists revealed a new microfluidic device nicknamed “pain-on-a-chip” that can objectively distinguish between different types of chronic pain, such as fibromyalgia and…
Swinburne University of Technology announced on Sunday an investment in H3D, supporting the commercialisation of AI-driven technology for dental devices based on research conducted at the university. H3D, which has already transformed the audio manufacturing industry by automating the design of custom hearing aids and related products, will now expand its cloud-based AI Computer-Aided Design…
Brisbane-based clinical-stage biotechnology company Vaxxas secured a new patent from the United States patent office covering its proprietary manufacturing technology for needle-free vaccine patches, the company announced on Wednesday. The patent covers Vaxxas’ printhead system that dispenses dried vaccine formulations onto the company’s high-density microarray patch (HD-MAP), which features thousands of microscopic projections on a…
Brisbane-based biotechnology company Vaxxas published new research on Wednesday showing promising results for its needle-free vaccine delivery technology. The company’s high-density microarray patch (HD-MAP) – a small patch containing thousands of tiny projections coated with vaccine – successfully delivered a DNA-based COVID-19 vaccine in animal testing, according to research published in the science journal Heliyon.…
This week in our Australia’s 50 Most Innovative Manufacturers series, we hear from Dr Chris Jeffery, CEO of Convergence Medical Robotics. The third-time founder shares some lessons learned from running successful companies; how to build the right culture, especially at the early stage; and how you can move fast while doing difficult things. By Brent…
